Axsome Therapeutics, Inc.
9 drugs in NADAC|0 Generic,9 Brand
Axsome Therapeutics, Inc. lists 9 NDCs in the CMS NADAC file (0 generic, 9 brand), at an average NADAC of $38.14 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
0G / 9B
Avg Price / Unit
$38.1432
$19.90 – $122.64
Avg 7d Change
0.00%
Across 5 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
solriamfetol market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Dopamine and Norepinephrine Reuptake Inhibitor therapeutic class
Review the broader class where Axsome Therapeutics, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Axsome Therapeutics, Inc. make?
Axsome Therapeutics, Inc. lists 9 NDCs in the CMS NADAC file — 0 generic and 9 brand products.
What is the average price of Axsome Therapeutics, Inc. drugs?
The average NADAC across Axsome Therapeutics, Inc.'s portfolio is $38.1432 per unit, ranging from $19.8977 to $122.6431.
What types of drugs does Axsome Therapeutics, Inc. make?
Axsome Therapeutics, Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Dopamine and Norepinephrine Reuptake Inhibitor (6), Aminoketone (2), Sigma-1 Agonist (2), Uncompetitive N-methyl-D-aspartate Receptor Antagonist (2), Nonsteroidal Anti-inflammatory Drug (1).
Has Axsome Therapeutics, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Axsome Therapeutics, Inc. in the openFDA feed.
How has Axsome Therapeutics, Inc.'s pricing changed recently?
Over the past 7 days, 3 Axsome Therapeutics, Inc. products rose and 2 fell, with a portfolio-wide average change of +0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SYMBRAVO 20-10 MG TABLET meloxicam, rizatriptan | $122.6431 per EA | -0.04% |
SUNOSI 75 MG TABLET solriamfetol | $31.3691 per EA | -0.02% |
SUNOSI 150 MG TABLET solriamfetol | $31.3429 per EA | +0.03% |
SUNOSI 75 MG TABLET solriamfetol | $29.5433 per EA | — |
SUNOSI 75 MG TABLET solriamfetol | $29.5433 per EA | — |
SUNOSI 150 MG TABLET solriamfetol | $29.5256 per EA | — |
SUNOSI 150 MG TABLET solriamfetol | $29.5256 per EA | — |
AUVELITY ER 45-105 MG TABLET dextromethorphan hydrobromide, bupropion hydrochloride | $19.8977 per EA | +0.01% |
AUVELITY ER 45-105 MG TABLET dextromethorphan hydrobromide, bupropion hydrochloride | $19.8977 per EA | +0.01% |